TEPPER ROBERT I 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed Jul 24, 2018
Insider Transaction Report
Form 4
TEPPER ROBERT I
Director10% Owner
Transactions
- Conversion
Common Stock
2018-07-23+2,705,334→ 2,716,384 total(indirect: By Funds) - Conversion
Series E Preferred Stock
2018-07-23−2,285,640→ 0 total(indirect: By Funds)→ Common Stock (266,934 underlying) - Conversion
Series F Preferred Stock
2018-07-23−1,000,000→ 0 total(indirect: By Funds)→ Common Stock (90,840 underlying) - Conversion
Series A Preferred Stock
2018-07-23−11,000,000→ 0 total(indirect: By Funds)→ Common Stock (999,180 underlying) - Conversion
Series E-1 Preferred Stock
2018-07-23−3,107,930→ 0 total(indirect: By Funds)→ Common Stock (282,308 underlying) - Purchase
Common Stock
2018-07-23$15.00/sh+266,667$4,000,005→ 2,983,051 total(indirect: By Funds) - Conversion
Series B Preferred Stock
2018-07-23−10,650,000→ 0 total(indirect: By Funds)→ Common Stock (967,389 underlying) - Conversion
Series D Preferred Stock
2018-07-23−1,086,411→ 0 total(indirect: By Funds)→ Common Stock (98,683 underlying)
Footnotes (2)
- [F1]On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
- [F2]These securities are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.